Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venkatraman Radhakrishnan

Showing results (81-90 of 146) with videos related to

Pageof 15
Sort By:
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|April 7, 2016
Voriconazole is a safe and effective anti-fungal prophylactic agent during induction therapy of acute myeloid leukemiaAkash Shah, Prasanth Ganesan, Venkatraman Radhakrishnan, et al.
Blood Research|July 26, 2022
Relevance of flow cytometric categorization and end-of-induction measurable residual disease assessment in pediatric and adult T-lymphoblastic leukemia patientsKarthik Bommannan, Jhansi Rani Arumugam, Venkatraman Radhakrishnan, et al.
Ophthalmology|April 3, 2012
Outcome, pathologic findings, and compliance in orbital retinoblastoma (International Retinoblastoma Staging System stage III) treated with neoadjuvant chemotherapy: a prospective studyVenkatraman Radhakrishnan, Seema Kashyap, Neelam Pushker, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|March 5, 2019
Chronic Myeloid Leukemia: Long-Term Outcome Data in the Imatinib EraPrasanth Ganesan, Trivadi S Ganesan, Venkatraman Radhakrishnan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 31, 2025
Dexamethasone for 12 weeks for reducing fatigue in patients receiving palliative chemotherapy: A Phase 3, Placebo-Controlled, Randomized Controlled TrialVenkatraman Radhakrishnan, Vidhya Gopalakrishnan, Gundrathi Vamsi Vihari, et al.
Journal of Global Oncology|September 23, 2018
Can Radiotherapy Be Omitted in Children With Hodgkin Lymphoma Who Achieve Metabolic Remission on Interim Positron Emission Tomography? Experience of a Tertiary Care Cancer Referral CenterSidharth Totadri, Venkatraman Radhakrishnan, Trivadi S Ganesan, et al.
World Neurosurgery|April 16, 2011
Imaging findings in intracranial aspergillus infection in immunocompetent patientsJitender Saini, Arun Kumar Gupta, Milan Babulal Jolapara, et al.
BMJ Supportive & Palliative Care|July 8, 2022
Neutropenic versus regular diet for acute leukaemia induction chemotherapy: randomised controlled trialVenkatraman Radhakrishnan, Perraju Bhaskar Bhuvan Lagudu, Devleena Gangopadhyay, et al.
Journal of Global Oncology|November 3, 2017
Pediatric Hodgkin Lymphoma Treated at Cancer Institute, Chennai, India: Long-Term OutcomeVenkatraman Radhakrishnan, Manikandan Dhanushkodi, Trivadi S Ganesan, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 27, 2026
Fludarabine - Total Body Irradiation-Based Myeloablative Conditioning for Haploidentical Hematopoietic Stem Cell Transplantation: A 10-Year Single Centre Real-World AnalysisPragadeesh Thamaraiselvan, Krishnarathinam Kannan, Jayachandran Perumal Kalaiyarasi, et al.
Pageof 15

Showing results (81-90 of 146) with videos related to

Sort By:
Pageof 15
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|April 7, 2016
Voriconazole is a safe and effective anti-fungal prophylactic agent during induction therapy of acute myeloid leukemiaAkash Shah, Prasanth Ganesan, Venkatraman Radhakrishnan, et al.
Blood Research|July 26, 2022
Relevance of flow cytometric categorization and end-of-induction measurable residual disease assessment in pediatric and adult T-lymphoblastic leukemia patientsKarthik Bommannan, Jhansi Rani Arumugam, Venkatraman Radhakrishnan, et al.
Ophthalmology|April 3, 2012
Outcome, pathologic findings, and compliance in orbital retinoblastoma (International Retinoblastoma Staging System stage III) treated with neoadjuvant chemotherapy: a prospective studyVenkatraman Radhakrishnan, Seema Kashyap, Neelam Pushker, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|March 5, 2019
Chronic Myeloid Leukemia: Long-Term Outcome Data in the Imatinib EraPrasanth Ganesan, Trivadi S Ganesan, Venkatraman Radhakrishnan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 31, 2025
Dexamethasone for 12 weeks for reducing fatigue in patients receiving palliative chemotherapy: A Phase 3, Placebo-Controlled, Randomized Controlled TrialVenkatraman Radhakrishnan, Vidhya Gopalakrishnan, Gundrathi Vamsi Vihari, et al.
Journal of Global Oncology|September 23, 2018
Can Radiotherapy Be Omitted in Children With Hodgkin Lymphoma Who Achieve Metabolic Remission on Interim Positron Emission Tomography? Experience of a Tertiary Care Cancer Referral CenterSidharth Totadri, Venkatraman Radhakrishnan, Trivadi S Ganesan, et al.
World Neurosurgery|April 16, 2011
Imaging findings in intracranial aspergillus infection in immunocompetent patientsJitender Saini, Arun Kumar Gupta, Milan Babulal Jolapara, et al.
BMJ Supportive & Palliative Care|July 8, 2022
Neutropenic versus regular diet for acute leukaemia induction chemotherapy: randomised controlled trialVenkatraman Radhakrishnan, Perraju Bhaskar Bhuvan Lagudu, Devleena Gangopadhyay, et al.
Journal of Global Oncology|November 3, 2017
Pediatric Hodgkin Lymphoma Treated at Cancer Institute, Chennai, India: Long-Term OutcomeVenkatraman Radhakrishnan, Manikandan Dhanushkodi, Trivadi S Ganesan, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 27, 2026
Fludarabine - Total Body Irradiation-Based Myeloablative Conditioning for Haploidentical Hematopoietic Stem Cell Transplantation: A 10-Year Single Centre Real-World AnalysisPragadeesh Thamaraiselvan, Krishnarathinam Kannan, Jayachandran Perumal Kalaiyarasi, et al.
Pageof 15